Skip to main content
SpringerLink
Log in

Comment on: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 04 January 2022

The Original Article was published on 15 October 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drwiega EN, Rodvold KA. Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update. Clin Pharmacokinet. 2021. https://doi.org/10.1007/s40262-021-01061-7 (Epub 15 Oct 2021).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Anan K, Oshima Y, Ogura T, Tanabe Y, Higashi A, Iwashita Y, et al. Safety and harms of bronchoalveolar lavage for acute respiratory failure: a systematic review and meta-analysis. Respir Investig. 2021. https://doi.org/10.1016/j.resinv.2021.07.008 (Epub 3 Sep 2021).

    Article  PubMed  Google Scholar 

  3. Khoubnasabjafari M, Rahimpour E, Jouyban A. Exhaled breath condensate as an alternative sample for drug monitoring. Bioanalysis. 2018;10:61–4.

    Article  CAS  Google Scholar 

  4. Davis MD, Montpetit AJ. Exhaled breath condensate an update. Immunol Allerg Clin N Am. 2018;38:667–78.

    Article  Google Scholar 

  5. Beck O. Chapter 30 – Drugs in breath. In: Beauchamp J, Davis C, Pleil J, editors. Breathborne biomarkers and the human volatilome. 2nd ed. Boston: Elsevier; 2020. p. 493–507.

    Chapter  Google Scholar 

  6. Khoubnasabjafari M, Fathi-Azarbayjani A, Rahimpour E, Jouyban-Gharamaleki V, Kim HY, Alffenaar J, et al. Concentration profile of tobramycin in exhaled breath condensate after inhalation of a single dose: a pilot study. J Drug Deliv Sci Technol. 2021;62:102394.

    Article  CAS  Google Scholar 

  7. Kruizinga MD, Birkhoff WAJ, van Esdonk MJ, Klarenbeek NB, Cholewinski T, Nelemans T, et al. Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis. Br J Clin Pharmacol. 2020;86:175–81.

    Article  CAS  Google Scholar 

  8. Herregodts J, Van Vooren S, Deschuyteneer E, Dhaese SAM, Stove V, Verstraete AG, et al. Measuring antibiotics in exhaled air in critically ill, non-ventilated patients: a feasibility and proof of concept study. J Crit Care. 2019;51:46–50.

    Article  CAS  Google Scholar 

  9. Gaohua L, Wedagedera J, Small BG, Almond L, Romero K, Hermann D, et al. Development of a multicompartment permeability-limited lung PBPK Model and its application in predicting pulmonary pharmacokinetics of antituberculosis drugs. CPT Pharmacomet Syst Pharmacol. 2015;4:605–13.

    Article  CAS  Google Scholar 

  10. Rowland Yeo K, Zhang M, Pan X, Ban Ke A, Jones HM, Wesche D, et al. Impact of disease on plasma and lung exposure of chloroquine, hydroxychloroquine and azithromycin: application of PBPK modeling. Clin Pharmacol Ther. 2020;108:976–84.

    Article  CAS  Google Scholar 

  11. Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14:498–509.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Medical Biochemistry and Clinical Analysis, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium

    Pieter-Jan De Sutter & An Vermeulen

  2. Department of Intensive Care Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium

    Jan De Waele

  3. Division of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

    Jan De Waele

Authors
  1. Pieter-Jan De Sutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan De Waele
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. An Vermeulen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pieter-Jan De Sutter.

Ethics declarations

Funding

No external funding was used in the preparation of this letter.

Conflicts of interest

Pieter-Jan De Sutter, Jan De Waele, and An Vermeulen have no conflicts of interests that are directly relevant to the contents of this letter.

Ethics approval

Not applicable.

Availability of data material and code

Not applicable.

Author contributions

AV, JDW and P-JDS contributed to the conception of this letter. The letter was drafted by P-JDS and critically revised by AV and JDW.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Sutter, PJ., De Waele, J. & Vermeulen, A. Comment on: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”. Clin Pharmacokinet 61, 335–336 (2022). https://doi.org/10.1007/s40262-021-01100-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-021-01100-3

Search

Navigation